Safety and dose modification for patients receiving niraparib. [electronic resource]
Producer: 20191223Description: 1784-1792 p. digitalISSN:- 1569-8041
- Administration, Oral
- Adult
- Body Weight
- Dose-Response Relationship, Drug
- Female
- Humans
- Incidence
- Indazoles -- administration & dosage
- Maintenance Chemotherapy -- adverse effects
- Neoplasm Recurrence, Local -- blood
- Ovarian Neoplasms -- blood
- Piperidines -- administration & dosage
- Platelet Count
- Poly(ADP-ribose) Polymerase Inhibitors -- administration & dosage
- Progression-Free Survival
- Retrospective Studies
- Risk Factors
- Thrombocytopenia -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.